Mafalda Oliveira
HOSPITAL UNIVERSITARIO VALL D'HEBRON
Barcelona / Spain
-
- Web of Science ResearcherID
- https://publons.com/researcher/I-1695-2015
583rd
Global
-
2203 InfluRatio
-
43 Indexed Publications in Altmetrics
Mentions data
Menciones por sus áreas de investigación
Clinical Medicine
- 1.9K
- Wikipedia
- 0
- News
- 204
- Policy
- 1
MENTIONS CHART
Global
-
2K Twitter
-
0 Wikipedia
-
204 News
-
1 Policy
Clinical Medicine
-
1.9K Twitter
-
0 Wikipedia
-
204 News
-
1 Policy
Trabajos con más influratio
Clinical Medicine
Todos sus trabajos en el área Clinical Medicine
Mentions
48
Twitter
0
Wikipedia
60
News
0
Policy
Article
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial
Llombart-Cussac, Antonio; Cortes, Javier; Pare, Laia; Galvan, Patricia; Bermejo, Begona; Martinez, Noelia; Vidal, Maria; Pernas, Sonia; Lopez, Rafael; Munoz, Montserrat; Nuciforo, Paolo; Morales, Serafin; Oliveira, Mafalda; de la Pena, Lorena; Pelaez, Alex
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(17)30021-9
OPEN ACCESS LEVEL /
Mentions
73
Twitter
0
Wikipedia
37
News
0
Policy
Article
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdx647
OPEN ACCESS LEVEL /
Bronze
Among researchers in
Clinical Medicine
- 281 st
- InfluRatio 2210
- 282 nd
- InfluRatio 2209
- 283 rd
- InfluRatio 2203
- 284 th
- InfluRatio 2192
- 285 th
- InfluRatio 2192
Más información
Influscience
Rankings
- BETA VERSION